Cingulate Inc.

Since breaking above $12 towards the end of 2023, biotech company $CING has been on a steep decline. Down over another 50% today as of now after the company announced a $3.75 million offering at $2 a share.

Share This Article

 

About the Author

Cingulate Inc.

Joey Ramson